Atul Dandekar, CSBO at Maze Therapeutics, Inc. (MAZE), sold 15,000 shares at $43.18 ($664K) on 2026-01-29, disclosed to the SEC on 2026-02-02.
Open-market sale of $664k MAZE by CSBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.18 | 1,200 | $52K | 7.8% |
| 2 | $43.18 | 1,200 | $52K | 7.8% |
| 3 | $44.04 | 3,500 | $154K | 23.2% |
| 4 | $44.04 | 3,500 | $154K | 23.2% |
| 5 | $45.01 | 2,800 | $126K | 19.0% |
| 6 | $45.01 | 2,800 |
| $126K |
| 19.0% |
| Total | $44.26 avg | 15,000 | $664K | 100% |
| Filing → |
| MAZE | SELL | 2026-08-31 | $207K | — | Filing → |
| MAZE | SELL | 2026-07-31 | $205K | — | Filing → |
| MAZE | SELL | 2026-07-01 | $210K | — | Filing → |